Denosumab-bmwo Injection
Product Images NDC 72606-059

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Denosumab-bmwo (NDC 72606-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Denosumab Bmwo 01)

A line graph showing corrected calcium levels (mmol/L and mg/dL) over study days for Denosumab 120 mg (N=23). The x-axis represents study days from baseline to day 57, and the y-axis shows calcium concentration with error bars indicating variability. The graph illustrates a general decline in calcium levels over time following treatment.*

FDA Label Image

Principal Display Panel (120 mg/1.7 mL Vial Carton)

Packaging label for Denosumab-bmwo Injection 120 mg/1.7 mL (70 mg/mL), a subcutaneous injection by CELLTRION USA, Inc. Label includes dosing instructions, storage conditions, a barcode, and ingredient information. The label states it is a single-dose vial to be administered by a healthcare provider and lists manufacturer details and distributor address in the USA and Republic of Korea.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.